1. Discussion: session 1. (December 2013) Authors: Sehouli, Jalid; del Campo, Josep M; Lorusso, Domenica Journal: Future oncology Issue: Volume 9:(2013) Supplement 12 Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discussion: session 2. (December 2013) Authors: del Campo, Josep M; Sehouli, Jalid; Lorusso, Domenica Journal: Future oncology Issue: Volume 9:(2013) Supplement 12 Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. Issue 8 (August 2018) Authors: Oza, Amit M; Matulonis, Ursula A; Malander, Susanne; Hudgens, Stacie; Sehouli, Jalid; del Campo, Josep M; Berton-Rigaud, Dominique; Banerjee, Susana; Scambia, Giovanni; Berek, Jonathan S; Lund, Bente; Tinker, Anna V; Hilpert, Felix; Vázquez, Isabel Palacio; D'Hondt, Véronique; Benigno, Benedict; ... Journal: Lancet oncology Issue: Volume 19:Issue 8(2018) Page Start: 1117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial. Issue 6 (June 2019) Authors: Vergote, Ignace; Scambia, Giovanni; O'Malley, David M; Van Calster, Ben; Park, Sang-Yoon; del Campo, Josep M; Meier, Werner; Bamias, Aristotelis; Colombo, Nicoletta; Wenham, Robert M; Covens, Al; Marth, Christian; Raza Mirza, Mansoor; Kroep, Judith R; Ma, Haijun; Pickett, Cheryl A; Monk, Bradley J Journal: Lancet oncology Issue: Volume 20:Issue 6(2019) Page Start: 862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗